GR79973B - - Google Patents
Info
- Publication number
- GR79973B GR79973B GR74742A GR840174742A GR79973B GR 79973 B GR79973 B GR 79973B GR 74742 A GR74742 A GR 74742A GR 840174742 A GR840174742 A GR 840174742A GR 79973 B GR79973 B GR 79973B
- Authority
- GR
- Greece
- Prior art keywords
- choline
- precursor
- neurotransmitters
- tryptophan
- relieving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49520283A | 1983-05-15 | 1983-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR79973B true GR79973B (el) | 1984-10-31 |
Family
ID=23967687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR74742A GR79973B (el) | 1983-05-16 | 1984-05-16 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0125900B1 (el) |
JP (1) | JPS60214734A (el) |
AT (1) | ATE45672T1 (el) |
CA (1) | CA1228301A (el) |
DE (1) | DE3479477D1 (el) |
ES (1) | ES8602409A1 (el) |
GR (1) | GR79973B (el) |
IL (1) | IL71819A (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657013B1 (fr) * | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | Composition dietetique a base de polypeptides et acides amines. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1114295A (en) * | 1977-11-02 | 1981-12-15 | John H. Growdon | Process and composition for treating disorders by administering choline or a compound that dissociates to choline |
DE2967257D1 (en) * | 1978-04-24 | 1984-11-22 | Massachusetts Inst Technology | Composition for regulating dopamine or norepinephrine levels in neuronal synapses |
DE2962429D1 (en) * | 1978-04-24 | 1982-05-19 | Massachusetts Inst Technology | A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels |
US4296119A (en) * | 1978-04-24 | 1981-10-20 | Massachusetts Institute Of Technology | Process and composition for reducing blood pressure in animals |
JPS5566512A (en) * | 1978-11-15 | 1980-05-20 | Massachusetts Inst Technology | Method and composition for treating difficulties by administration of choline or choline dissociating compound |
US4221784A (en) * | 1979-04-05 | 1980-09-09 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering lecithin |
DE2915433A1 (de) * | 1979-04-17 | 1980-10-30 | Christensen Plantorgan Werk | Verwendung von physiologisch vertraeglichen methyldonatoren |
US4397866A (en) * | 1979-05-07 | 1983-08-09 | Massachusetts Institute Of Technology | Process for increasing glycine levels in the brain and spinal cord |
-
1984
- 1984-05-11 EP EP84303195A patent/EP0125900B1/en not_active Expired
- 1984-05-11 DE DE8484303195T patent/DE3479477D1/de not_active Expired
- 1984-05-11 AT AT84303195T patent/ATE45672T1/de not_active IP Right Cessation
- 1984-05-13 IL IL71819A patent/IL71819A/xx not_active IP Right Cessation
- 1984-05-14 JP JP59094739A patent/JPS60214734A/ja active Granted
- 1984-05-15 ES ES532873A patent/ES8602409A1/es not_active Expired
- 1984-05-16 GR GR74742A patent/GR79973B/el unknown
- 1984-05-16 CA CA000454518A patent/CA1228301A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL71819A (en) | 1987-12-31 |
JPH0141124B2 (el) | 1989-09-04 |
ATE45672T1 (de) | 1989-09-15 |
EP0125900B1 (en) | 1989-08-23 |
IL71819A0 (en) | 1984-09-30 |
ES532873A0 (es) | 1985-12-16 |
EP0125900A1 (en) | 1984-11-21 |
ES8602409A1 (es) | 1985-12-16 |
JPS60214734A (ja) | 1985-10-28 |
DE3479477D1 (en) | 1989-09-28 |
CA1228301A (en) | 1987-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1943388A (en) | 3-indolepyruvic acid derivatives and pharmaceutical use thereof | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ES8304797A1 (es) | "procedimiento para la preparacion de nuevas formas orales de dipiridamol, en forma de granulados, pastillas o tabletas". | |
ES8601108A1 (es) | Procedimiento para la obtencion de eglinas b o c modificadas | |
DK442287D0 (da) | Farmaceutisk praeparat indeholdende l-3,4-dihydroxyphenylalanin (l-dopa) som aktiv bestanddel og fremgangsmaade til fremstilling af et saadant praeparat | |
GR3003153T3 (en) | Therapeutic composition containing gamma-linolenicacid and an assimilable form of calcium | |
DE69316013D1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
GR3002842T3 (en) | N-substituted 3-piperidine-or 3-pyridine-carboxylic acids and derivatives thereof | |
IL83775A (en) | Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis | |
GR79973B (el) | ||
SE8803583L (sv) | Farmaceutisk komposition | |
DE2966809D1 (en) | 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them | |
ES2038847T3 (es) | Proceso para la preparacion de una composicion farmacutica conteniendo zidovudine e inosiplex para el tratamiento del sida y sindromes afines. | |
BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
AU1621888A (en) | Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes | |
NO874241D0 (no) | Terapeutisk aktive salter. | |
IL88726A0 (en) | Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
DE3879489D1 (de) | Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. | |
ATE153859T1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
DK0434989T3 (da) | Fremgangsmåde til forbedring af ventilationen under søvn og til behandling af søvnrelaterede ventilationsabnormaliteter | |
DK0425109T3 (da) | 3-substitueret-2-oxindolderivater som inhibitorer for interleukin-1-biosyntese | |
HK1013296A1 (en) | Analogs of thymosin alpha 1 |